Boothbay Fund Management LLC Takes $1.45 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Boothbay Fund Management LLC purchased a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 68,442 shares of the company's stock, valued at approximately $1,449,000. Boothbay Fund Management LLC owned approximately 0.05% of Surgery Partners at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. KBC Group NV lifted its stake in shares of Surgery Partners by 66.1% in the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after purchasing an additional 1,577 shares during the last quarter. MeadowBrook Investment Advisors LLC raised its holdings in Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after buying an additional 1,460 shares during the period. Tower Research Capital LLC TRC lifted its position in Surgery Partners by 279.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock worth $228,000 after buying an additional 7,925 shares during the last quarter. Empowered Funds LLC purchased a new position in Surgery Partners during the fourth quarter worth $245,000. Finally, KLP Kapitalforvaltning AS bought a new position in Surgery Partners during the fourth quarter valued at $273,000.

Surgery Partners Trading Up 2.2 %

Shares of Surgery Partners stock traded up $0.48 on Thursday, hitting $22.43. 788,494 shares of the company traded hands, compared to its average volume of 1,101,531. Surgery Partners, Inc. has a 52 week low of $19.50 and a 52 week high of $33.97. The company has a market cap of $2.86 billion, a PE ratio of -46.73, a PEG ratio of 19.21 and a beta of 2.40. The stock's 50 day moving average price is $22.85 and its 200-day moving average price is $23.93. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $864.40 million during the quarter, compared to analysts' expectations of $828.09 million. Equities research analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on SGRY. Benchmark restated a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a report on Monday, April 21st. Royal Bank of Canada reissued an "outperform" rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Tuesday, March 25th. Finally, Macquarie dropped their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $34.75.

Insiders Place Their Bets

In related news, insider Harrison R. Bane sold 56,315 shares of the business's stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the transaction, the insider now owns 107,037 shares of the company's stock, valued at $2,744,428.68. The trade was a 34.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO David T. Doherty sold 6,733 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. This trade represents a 4.27 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 106,622 shares of company stock worth $2,717,860 in the last three months. Corporate insiders own 2.30% of the company's stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.